Capital Research Global Investors 13D and 13G filings for Haemonetics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 12:54 pm Sale | 2024-11-07 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 4,442,653 8.700% | -2,080,915 (-31.90%) | Filing |
| 2024-02-09 5:49 pm Purchase | 2024-02-07 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 6,523,568 12.900% | 567,504 (+9.53%) | Filing |
| 2023-02-13 3:32 pm Purchase | 2023-02-14 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 5,956,064 11.800% | 504,058 (+9.25%) | Filing |
| 2022-04-08 11:19 am Purchase | 2022-04-11 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 5,452,006 10.700% | 3,402,873 (+166.06%) | Filing |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 2,049,133 4.000% | -726,503 (-26.17%) | Filing |
| 2021-06-10 11:46 am Sale | 2021-06-10 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 2,775,636 5.400% | -2,862,099 (-50.77%) | Filing |
| 2021-02-16 3:11 pm Purchase | 2021-02-16 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 5,637,735 11.100% | 437,670 (+8.42%) | Filing |
| 2020-11-10 12:33 pm Purchase | 2020-11-10 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 5,200,065 10.200% | 2,505,265 (+92.97%) | Filing |
| 2020-02-14 12:03 pm Purchase | 2019-12-31 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 2,694,800 5.300% | 800,580 (+42.26%) | Filing |